145 related articles for article (PubMed ID: 21118967)
1. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in apoptosis pathway and the risk of ovarian cancer.
Xie H; Tao W; Wu X; Gu J
Oncotarget; 2016 Aug; 7(35):56737-56745. PubMed ID: 27462919
[TBL] [Abstract][Full Text] [Related]
3. Functional microRNA binding site variants.
Yuan Y; Weidhaas JB
Mol Oncol; 2019 Jan; 13(1):4-8. PubMed ID: 30536617
[TBL] [Abstract][Full Text] [Related]
4. Parallel Reporter Assays Identify Altered Regulatory Role of rs684232 in Leading to Prostate Cancer Predisposition.
Ren N; Liu Q; Yan L; Huang Q
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445492
[TBL] [Abstract][Full Text] [Related]
5. Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
Goode EL; DeRycke M; Kalli KR; Oberg AL; Cunningham JM; Maurer MJ; Fridley BL; Armasu SM; Serie DJ; Ramar P; Goergen K; Vierkant RA; Rider DN; Sicotte H; Wang C; Winterhoff B; Phelan CM; Schildkraut JM; Weber RP; Iversen E; Berchuck A; Sutphen R; Birrer MJ; Hampras S; Preus L; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Song H; Tyrer J; Pharoah PP; Konecny G; Sellers TA; Ness RB; Sucheston LE; Odunsi K; Hartmann LC; Moysich KB; Knutson KL
PLoS One; 2013; 8(1):e53903. PubMed ID: 23382860
[TBL] [Abstract][Full Text] [Related]
6. A microRNA-related single nucleotide polymorphism of the
Guo Z; Wang H; Li Y; Li B; Li C; Ding C
Biomed Rep; 2013 Jul; 1(4):545-548. PubMed ID: 24648983
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility.
Ziliak D; Gamazon ER; Lacroix B; Kyung Im H; Wen Y; Huang RS
Mol Cancer Ther; 2012 Sep; 11(9):2054-61. PubMed ID: 22752226
[TBL] [Abstract][Full Text] [Related]
8. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Seyhan AA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
[TBL] [Abstract][Full Text] [Related]
10. GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer.
Wu L; Zhang Y; Zheng C; Zhao F; Lin Y
BMC Womens Health; 2023 Jul; 23(1):396. PubMed ID: 37507701
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeleton Protein BmACT1 Is Potential for the Autophagic Function and Nuclear Localization of BmAtg4b in
Ma Q; Deng J; Li H; Huang Z; Tian L
Cells; 2023 Mar; 12(6):. PubMed ID: 36980240
[TBL] [Abstract][Full Text] [Related]
12. KRAS Hijacks the miRNA Regulatory Pathway in Cancer.
Bortoletto AS; Parchem RJ
Cancer Res; 2023 May; 83(10):1563-1572. PubMed ID: 36946612
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the Occurrence of Genetic Variants of Single Nucleotide Polymorphism in microRNA Processing Genes and the Risk of Developing Multiple Sclerosis.
Basak J; Piotrzkowska D; Majsterek I; Kucharska E
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551880
[TBL] [Abstract][Full Text] [Related]
14. Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.
Kandettu A; Adiga D; Devi V; Suresh PS; Chakrabarty S; Radhakrishnan R; Kabekkodu SP
Genes Dis; 2022 Nov; 9(6):1443-1465. PubMed ID: 36157483
[TBL] [Abstract][Full Text] [Related]
15. Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma.
Marinović S; Škrtić A; Catela Ivković T; Poljak M; Kapitanović S
Hum Cell; 2021 Sep; 34(5):1455-1465. PubMed ID: 34235620
[TBL] [Abstract][Full Text] [Related]
16. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.
Galka-Marciniak P; Urbanek-Trzeciak MO; Nawrocka PM; Kozlowski P
Nucleic Acids Res; 2021 Jan; 49(2):601-620. PubMed ID: 33406242
[TBL] [Abstract][Full Text] [Related]
17. Impact of Genetic Variation in
Wu H; Gao H; Li A; Xie Y; Jia Z; Yang Z; Zhang H; Zhang Z; Zhang X
J Oncol; 2020; 2020():7593143. PubMed ID: 32351566
[TBL] [Abstract][Full Text] [Related]
18. Association of microRNA biosynthesis genes XPO5 and RAN polymorphisms with cancer susceptibility: Bayesian hierarchical meta-analysis.
Shao Y; Shen Y; Zhao L; Guo X; Niu C; Liu F
J Cancer; 2020; 11(8):2181-2191. PubMed ID: 32127945
[TBL] [Abstract][Full Text] [Related]
19. Multiple genetic factors affecting the pharmacokinetic and pharmacodynamic processes of tacrolimus in Chinese myasthenia gravis patients.
Meng HY; Li X; Jin WL; Yan CK; Dong XH; Xu Q; Peng YY; Li ZB; Li Y; Luo ZH; Xu LQ; Yang H
Eur J Clin Pharmacol; 2020 May; 76(5):659-671. PubMed ID: 31955224
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism in DGCR8 is associated with late onset of preeclampsia.
Huang X; Li Z; Lei J; Wang D; Zhang Y
BMC Med Genet; 2019 Sep; 20(1):151. PubMed ID: 31484500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
